Potential genetic biomarkers in the early diagnosisof Alzheimer disease: APOE and BIN1

Kaya, Gülhan; Gündüz, Esra; Acar, Muradiye; Hatipoğlu, Ömer Faruk; Acar, Burcu; İlhan, Atilla; Gündüz, Mehmet

doi:10.3906/sag-1405-96

Cited by 6 publications

(1 citation statement)

References 59 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The first, rs6733839, has been widely reported as a risk variant in various populations, however, in AAs there was no strong evidence of association 37 . The second, rs744373, was identified as a risk variant in Japanese with no evidence for association in AA or Turkish populations 38 . Following targeted sequencing and follow-up genotyping, Vardarajan et al, 2015 found BIN1:p.Lys358Arg (rs138047593) in 8 Caucasian and 6 Hispanic LOAD patients; segregation was shown in 2 out of 6 Caribbean Hispanic families 39 .…”

Section: Translatability Of Known Ad Gwas Hits To Datementioning

confidence: 99%

How understudied populations leverage our understanding of Alzheimer’s disease genetics

Dehghani

Brás

Guerreiro

2020

Alzheimer's & Dementia

View full text Add to dashboard Cite

Background The majority of genome‐wide association studies have been conducted using samples with a European genetic background. As a field, we acknowledge this limitation and the need to increase the diversity of populations studied. A major challenge when designing and conducting such studies is to assimilate large samples sizes to have enough statistical power to detect variants associated with disease, particularly when trying to identify variants with low and rare minor allele frequencies. In this study, we aimed to illustrate the benefits, to genetic characterization of Alzheimer’s disease (AD), in researching currently understudied populations. This is important for both fair representation of world populations and the translatability of findings. Method We have conducted a thorough literature search to understand the contributions of studies, on different populations, to AD genetics. Result To accomplish this, we have systematically quantified the number of studies identifying mutations in known disease‐causing genes, in all countries across the world, and discussed the contributions of research in understudied populations to the identification of novel genetic factors in this disease. Related to this, we compared the varied effects of genome‐wide significant SNPs across populations by focusing on loci that show different association profiles between populations (a key example being APOE). Conclusion This work functions to both highlight how understudied populations have furthered our understanding of AD genetics, and to help us gage our progress on understanding the genetic architecture of this disease in all populations.

show abstract

Section: Translatability Of Known Ad Gwas Hits To Datementioning

confidence: 99%

How understudied populations leverage our understanding of Alzheimer’s disease genetics

Dehghani

Brás

Guerreiro

2020

Alzheimer's & Dementia

View full text Add to dashboard Cite

show abstract

Bosnian study ofAPOEdistribution (BOSAD): a comparison with other European populations

Adler

Urbańska

et al. 2017

Annals of Human Biology

View full text Add to dashboard Cite

show abstract

How understudied populations have contributed to our understanding of Alzheimer’s disease genetics

Dehghani

Brás

Guerreiro

2021

Brain

View full text Add to dashboard Cite

The majority of genome-wide association studies have been conducted using samples with a broadly European genetic background. As a field, we acknowledge this limitation and the need to increase the diversity of populations studied. A major challenge when designing and conducting such studies is to assimilate large samples sizes so that we attain enough statistical power to detect variants associated with disease, particularly when trying to identify variants with low and rare minor allele frequencies. In this review, we aimed to illustrate the benefits to genetic characterization of Alzheimer’s disease, in researching currently understudied populations. This is important for both fair representation of world populations and the translatability of findings. To that end, we conducted a literature search to understand the contributions of studies, on different populations, to Alzheimer’s disease genetics. Using both PubMed and Alzforum Mutation Database, we systematically quantified the number of studies reporting variants in known disease-causing genes, in a worldwide manner, and discuss the contributions of research in understudied populations to the identification of novel genetic factors in this disease. Additionally, we compared the effects of genome-wide significant single nucleotide polymorphisms across populations by focusing on loci that show different association profiles between populations (a key example being APOE). Reports of variants in APP, PSEN1 and PSEN2 can initially determine whether patients from a country have been studied for Alzheimer’s disease genetics. Most genome-wide significant associations in non-Hispanic white genome-wide association studies do not reach genome-wide significance in such studies of other populations, with some suggesting an opposite effect direction; this is likely due to much smaller sample sizes attained. There are, however, genome-wide significant associations first identified in understudied populations which have yet to be replicated. Familial studies in understudied populations have identified rare, high effect variants, which have been replicated in other populations. This work functions to both highlight how understudied populations have furthered our understanding of Alzheimer’s disease genetics, and to help us gauge our progress in understanding the genetic architecture of this disease in all populations.

show abstract

Potential genetic biomarkers in the early diagnosisof Alzheimer disease: APOE and BIN1

Cited by 6 publications

References 59 publications

How understudied populations leverage our understanding of Alzheimer’s disease genetics

How understudied populations leverage our understanding of Alzheimer’s disease genetics

Bosnian study ofAPOEdistribution (BOSAD): a comparison with other European populations

How understudied populations have contributed to our understanding of Alzheimer’s disease genetics

Contact Info

Product

Resources

About